SEC Form 3 · accession 0001104659-15-077362
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Harding
Officer — Chief Commercial Officer
Period of report
Oct 30, 2015
Accepted (ET)
Nov 9, 2015 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney